PRTODAY / NewswireToday Free press release distribution service network

Written by / Agency / Source: Gevo, Inc.

Check Ads Availability|e-mail Article


Are you the owner of this article?, Turn it PREMIUM with your LOGO instead - and make it 3rd party Ads-Free! within the next hour!

Gevo’s Isobutanol Secures EPA Registration - First Isobutanol to receive Environmental Protection Agency (EPA) registration as a fuel additive - Gevo.com
Gevo’s Isobutanol Secures EPA Registration

 

NewswireToday - /newswire/ - Englewood, CO, United States, 2010/11/11 - First Isobutanol to receive Environmental Protection Agency (EPA) registration as a fuel additive - Gevo.com.

   
 
Your Banner Ad Here instead - Showing along with ALL Articles covering Pharma/BioTech/Nutrition Announcements

Replace these Affiliate Programs at ANYTIME! Your banner here within the next hour. Learn How!


 

Gevo, Inc., a privately held renewable chemicals and advanced biofuels company, announced today that it received notification that its isobutanol had successfully cleared registration with the U.S. EPA as a fuel additive. Gevo’s isobutanol is the first isobutanol to be listed in the EPA’s Fuel Registration Directory and is now approved for blending with gasoline.

"We’ve taken another important step in commercializing our product in the near term, said Gevo CEO Dr. Patrick Gruber. "Along with the chemicals market, selling isobutanol as a low Reid Vapor Pressure (RVP) biofuel blendstock is one of our most important opportunities."

Gevo believes isobutanol is a very attractive alcohol fuel gasoline blendstock. It has higher energy density than ethanol and lower RVP. RVP is regulated by the EPA under the Clean Air Act. Low RVP gasoline blends are required in many urban areas in order to comply with state level ozone attainment plans. Under the Renewable Fuel Standard II, isobutanol qualifies for 30 percent more renewable fuel value or Renewable Identification Number (RIN) than ethanol for obligated parties. Isobutanol has characteristics that make it an attractive alternative to other gasoline components like alkylate and aromatics, which should enable refiners to modify their gasoline formulation in ways that increase their operating margins. These various attributes also provide refiners with valuable options in meeting their clean air and renewable fuel obligations.

Gevo’s isobutanol can be used directly as a specialty chemical, as a gasoline and jet fuel blendstock, and through conversion into plastics, fibers, rubber and other polymers. Gevo will soon begin the retrofit of its first 22 million gallons per year (MPGY) ethanol facility in Luverne, MN to produce 18 MGPY of isobutanol. The Company plans to expand its isobutanol production via the retrofit of additional ethanol facilities over the next few years. In the future, Gevo intends to produce cellulosic isobutanol once biomass conversion technology is commercially available.

About Gevo

Gevo (gevo.com) is developing capital efficient biorefinery systems to provide renewable, cost-effective building block products to the fuel and chemical industries. The Company seeks to convert renewable raw materials into isobutanol and renewable hydrocarbons that can be directly integrated on a “drop in” basis into existing fuel and chemical products to deliver environmental and economic benefits. Gevo is committed to a sustainable biobased economy that meets society’s needs for plentiful food and clean air and water.

 
 
Your Banner Ad Here instead - Showing along with ALL Articles covering Pharma/BioTech/Nutrition Announcements

Replace these Affiliate Programs at ANYTIME! Your banner here within the next hour. Learn How!


 

Written by / Agency / Source: Gevo, Inc.

 
 

Availability: All Regions (Including Int'l)

 

Traffic Booster: [/] Quick Newswire Today Visibility Checker

 

Distribution / Indexing: [+]

 
 
# # #
 

 
  Your Banner Ad showing on ALL
Pharma/BioTech/Nutrition articles,
CATCH Visitors via Your Competitors Announcements!


Gevo’s Isobutanol Secures EPA Registration

Company website links NOT available to basic submissions
It is OK to republish and/or LINK any newswire for any legitimate media purpose as long as you name Newswire Today and LINK as the source.
 
  Is this your article?
Activate ALL web links and social stream by Upgrading to Press Release PREMIUM Plan Now!

|
Publisher Contact: Shweta Agarwal - Schwartz Communications 
781-684-0770 gevo[.]schwartzcomm.com
 
Newswire Today - PRZOOM / PRTODAY disclaims any content contained in this article. If you need/wish to contact the company who published the current release, you will need to contact them - NOT us. Issuers of articles are solely responsible for the accuracy of their content. Our complete disclaimer appears here.
IMPORTANT INFORMATION: Issuance, publication or distribution of this press release in certain jurisdictions could be subject to restrictions. The recipient of this press release is responsible for using this press release and the information herein in accordance with the applicable rules and regulations in the particular jurisdiction. This press release does not constitute an offer or an offering to acquire or subscribe for any Gevo, Inc. securities in any jurisdiction including any other companies listed or named in this release.

Pharma/BioTech/Nutrition via RSSAdd NewswireToday - PRZOOM Headline News to FeedBurner
Find who RetweetFollow @NewswireTODAY



Are you the owner of this article?, Turn it PREMIUM with your LOGO instead - and make it 3rd party Ads-Free! within the next hour!


Read Latest Articles From Gevo, Inc. / Company Profile


Read Pharma/BioTech/Nutrition Most Recent Related Newswires:

Sub-Sahara Africa - Increase in Western Lifestyles Leads to Dire Need for Chronic Prescription Drugs Finds Frost & Sullivan
BD Initiates New Industry Alliance to Combat Rising Opioid Crisis
BTG and Society of Interventional Oncology to Explore Role of Minimally Invasive Therapies in Immuno-oncology
Ipsen to Acquire a Portfolio of Select Consumer Healthcare Products from Sanofi
BD Announces Early Access Program for BD Resolve™ Single-Cell Analysis Platform
Precision Medicine Unlocks the Future of Targeted Therapy in the Global Healthcare Industry Finds Frost & Sullivan
Sciformix Corporation Receives Prestigious 2017 Global Outsourcing Customer Service Leadership Award from Frost & Sullivan
Arven Pharmaceuticals Selects GE Healthcare’s FlexFactory to Improve Turkish and Regional Access to Biopharmaceuticals
Ipsen to Acquire Primary Care Platform in Italy from Akkadeas Pharma
Cost-Containment and Client-Centric Services Catalyse European Custom Procedure Trays and Packs Market Finds Frost & Sullivan
New BD Institute for Medication Management Excellence Aims to Improve Patient Safety and Outcomes through Collaboration
New Varicose Vein Treatment Offers Minimally Invasive Non Surgical Procedure to Canadians
Greenphire and Exostar Partner to Deliver Seamless, Secure Access to Clinical Research Site Payment Solution
PleurX™ Catheter System Receives FDA 510(k) Clearance for Specific Non-Malignant Recurrent Pleural Effusions
First Pulmonary Embolism Patients in Hong Kong Treated with the EKOS® System

Boost Your Social Network
& Crowdfunding Campaigns


LIFETIME SOCIAL MEDIA WALL
NewswireToday Celebrates 10 Years in Business


PREMIUM Members


Visit  La Bella Bakery Artisan Bakery Arizona

Visit  JobsWare.com





 
  ©2017 Newswire Today — Limelon Advertising, Co.
Home | About | Advertise/Pricing | Contact | Investors | Privacy/TOS | Sitemap | FRANCAIS
newswire, PR free press releases distribution service magazines engine news alert newsroom press room breaking news public relations articles company news alerts newswiredistribution ezine bizentrepreneur biznewstoday digital business report market search pr firms agencies reports distri-bution today investor relation successful internet entrepreneurs newswire distribution prtoday.com freenewswiredistribution asianewstoday bizwiretoday USA pr UK today - NOT affiliated with PRNewswire as we declined their partnership offer in 2013
 
PRTODAY & NewswireTODAY are NOT affiliated with USA TODAY (usatoday.com)